These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18782025)

  • 1. Innovative therapeutic strategies for restoring lymphocyte functions in septic patients.
    Turrel F; Guignant C; Venet F; Lepape A; Monneret G
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):181-6. PubMed ID: 18782025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.
    Monneret G; Venet F; Pachot A; Lepape A
    Mol Med; 2008; 14(1-2):64-78. PubMed ID: 18026569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reversing ICU-acquired immunosuppression: an innovative biomarker-guided therapeutic strategy for decreasing sepsis mortality and nosocomial infection rate].
    Monneret G; Lepape A; Venet F
    Pathol Biol (Paris); 2011 Dec; 59(6):329-33. PubMed ID: 21981928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of T regulatory cells in human sepsis.
    Kessel A; Bamberger E; Masalha M; Toubi E
    J Autoimmun; 2009; 32(3-4):211-5. PubMed ID: 19345068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation.
    Denstaedt SJ; Singer BH; Standiford TJ
    Front Immunol; 2018; 9():2446. PubMed ID: 30459764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry developments and perspectives in clinical studies: examples in ICU patients.
    Venet F; Guignant C; Monneret G
    Methods Mol Biol; 2011; 761():261-75. PubMed ID: 21755455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cell populations in sepsis and trauma.
    Venet F; Chung CS; Monneret G; Huang X; Horner B; Garber M; Ayala A
    J Leukoc Biol; 2008 Mar; 83(3):523-35. PubMed ID: 17913974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of regulatory T cells in the pathogenesis of sepsis and its clinical implication.
    Jiang LN; Yao YM; Sheng ZY
    J Interferon Cytokine Res; 2012 Aug; 32(8):341-9. PubMed ID: 22799563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of human ghrelin and growth hormone: Attenuation of immunosuppression in septic aged rats.
    Zhou M; Yang WL; Aziz M; Ma G; Wang P
    Biochim Biophys Acta Mol Basis Dis; 2017 Oct; 1863(10 Pt B):2584-2593. PubMed ID: 28115288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy.
    Monneret G; Venet F
    Cytometry B Clin Cytom; 2016 Jul; 90(4):376-86. PubMed ID: 26130241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of sepsis on CD4 T cell immunity.
    Cabrera-Perez J; Condotta SA; Badovinac VP; Griffith TS
    J Leukoc Biol; 2014 Nov; 96(5):767-77. PubMed ID: 24791959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate lymphocyte subsets and their immunoregulatory roles in burn injury and sepsis.
    Schneider DF; Glenn CH; Faunce DE
    J Burn Care Res; 2007; 28(3):365-79. PubMed ID: 17438501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7 and Its Beneficial Role in Sepsis-Induced T Lymphocyte Dysfunction.
    de Roquetaillade C; Monneret G; Gossez M; Venet F
    Crit Rev Immunol; 2018; 38(6):433-451. PubMed ID: 31002599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 4 deficiency increases resistance in sepsis-induced immune dysfunction.
    Cao C; Chai Y; Shou S; Wang J; Huang Y; Ma T
    Int Immunopharmacol; 2018 Jan; 54():169-176. PubMed ID: 29149705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis.
    Ayala A; Chaudry IH
    Shock; 1996; 6 Suppl 1():S27-38. PubMed ID: 8828095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of regulatory T cells prevents secondary chronic infection but increases the mortality of subsequent sub-acute infection in sepsis mice.
    Huo R; Wang L; Wang X; Zhao Y; Wang Y; Zhao X; Chang L; Liu SL; Tong D; Zhang H; Huang Y
    Oncotarget; 2016 Mar; 7(10):10962-75. PubMed ID: 26918357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis-induced lymphopenia in sepsis and other severe injuries.
    Girardot T; Rimmelé T; Venet F; Monneret G
    Apoptosis; 2017 Feb; 22(2):295-305. PubMed ID: 27812767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential alterations of tissue T-cell subsets after sepsis.
    Sharma A; Yang WL; Matsuo S; Wang P
    Immunol Lett; 2015 Nov; 168(1):41-50. PubMed ID: 26362089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways.
    Hotchkiss RS; Osmon SB; Chang KC; Wagner TH; Coopersmith CM; Karl IE
    J Immunol; 2005 Apr; 174(8):5110-8. PubMed ID: 15814742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions.
    Venet F; Lepape A; Monneret G
    Crit Care; 2011; 15(5):231. PubMed ID: 22017882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.